LEUKEMIA & LYMPHOMA SOCIETY
Leukemia & Lymphoma Society, a voluntary health organization, funds research, finds cures, and offers treatments for blood cancer patients.
LEUKEMIA & LYMPHOMA SOCIETY
Founded:
1944-01-01
Status:
Active
Contact:
(800) 482-8326
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network Apache IPv6 Google Maps
Current Advisors List
Current Employees Featured
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-06-13 | ImCheck Therapeutics | Leukemia & Lymphoma Society investment in Series C - ImCheck Therapeutics | 96 M EUR |
| 2021-08-18 | Immunitas Therapeutics | Leukemia & Lymphoma Society investment in Series B - Immunitas Therapeutics | 58 M USD |
| 2021-03-30 | Immune-Onc Therapeutics | Leukemia & Lymphoma Society investment in Series B - Immune-Onc Therapeutics | 73 M USD |
| 2021-03-03 | Caribou Biosciences | Leukemia & Lymphoma Society investment in Series C - Caribou Biosciences | 115 M USD |
| 2020-03-12 | Kymera Therapeutics | Leukemia & Lymphoma Society investment in Corporate Round - Kymera Therapeutics | N/A |
| 2019-08-12 | University of Arkansas for Medical Sciences | Leukemia & Lymphoma Society investment in Grant - University of Arkansas for Medical Sciences | 542.49 K USD |
| 2019-08-07 | Forty Seven | Leukemia & Lymphoma Society investment in Post-IPO Equity - Forty Seven | 6 M USD |
| 2014-08-28 | OncoPep | Leukemia & Lymphoma Society investment in Series B - OncoPep | 6.9 M USD |
| 2011-06-23 | Epizyme | Leukemia & Lymphoma Society investment in Venture Round - Epizyme | 7.5 M USD |
Key Employee Changes
| Date | New article |
|---|---|
| 2020-03-02 | The Leukemia & Lymphoma Society Announces New Chief Operating Officer, Chief Marketing Officer and General Counsel |